Author

Zihan Jiang

University of Shanghai for Science and TechnologyPrimary ORCID profile (0000-0003-3996-0669 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Zihan JiangiD1 paper · Kunming Institute of Botany

Biology Disciplines

Click to filter author papers

Synthetic Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Ni Zuo· 1 shared Weihong JiangiD· 1 shared Weitong Wang· 1 shared X L CaiiD· 1 shared Xin SongiD· 1 shared Yang GuiD· 1 shared Zequan Ren· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSynthetic Biology

Ni Zuo

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Engineered probiotic Escherichia coli-mediated intestinal nicotine clearance alleviates nonalcoholic steatohepatitis in mice

Ni Zuo, X L Cai, Weitong Wang, Zequan Ren, Zihan Jiang, Weihong Jiang, Xin Song, Yang Gu

The paper engineers a probiotic Escherichia coli to degrade nicotine in the gut, reducing NASH in mice by improving liver function and blocking the gut-liver axis.

bioRxiv · Jul 3, 2026 · PreprintSynthetic Biology